Safety and immunogenicity of Bacillus Calmette-Guerin vaccine in children born to HIV-1 infected women

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 31, Issue 3, 2000, Pages 482-486

  Thaithumyanon, Pimolrat ^a   Thisyakorn, Usa ^a   Punnahitananda, Sunti ^a   Praisuwanna, Pramote ^a   Ruxrungtham, Kiat ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INFANT; MALE; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; THAILAND; TUBERCULIN TEST; TUBERCULOSIS;

BCG VACCINE; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; THAILAND; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0034280179     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Alhedy SMA, Sivanantharajak K. Keloids in various races. Plast Reconstr Surg 1969; 44: 565.
2. Anonymous. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43 (RR 12): 1-10.
3. American Academy of Pediatrics, Committee on Infectious Disease. Update on tuberculosis skin testing of children. Pediatrics 1996; 97: 282-4.
4. American Thoracic Society, Medical Section of the American Lung Association. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990; 142: 725-35.
5. Besnard M, Sauvion S, Offredo C, et al. Bacillus Calmette-Guerin infection after vaccination of human immunodeficincy virus-infected children. Pediatr Infect Dis J 1993; 12: 993-7.
6. Centers for Disease Control. Use of BCG vaccines in the control of tuberculosis: a joint statement by the ACIP and the advisory committee for elimination of tuberculosis. MMWR 1988; 37: 663-75.
7. D'Arcy Hart P, Sutherland I, Thomas J. The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensivity and to technical variations in the vaccines. Tubercle 1967; 48: 201-10.
8. Gouzales B, Moreno S, Burdach R, et al. Clinical presentation of Bacillus Calmette-Guerin infections in patients with immnodeficiency syndromes. Pediatr Infect Dis J 1989; 8: 201-6.
9. Lallemant-Le Coeur S, Lallermant M, Cheynicer D, et al. Bacillus Calmette-Guerin immunization in infants born to HIV-1-seropositive mothers. AIDS 1991; 5: 195-9.
10. Msellati P, Dabis F, Lapage P, et al. BCG vaccination and pediatric HIV infection-Rwanda, 1988-1990. MMWR 1991; 40: 833-6.
11. Payanandana V, Bamrungtrakul T, Konjanar S, et al. Report on an internal evaluation of the national tuberculosis programme Thailand, 1993; 16: 2341.
12. Pouchot J, Grasland A, Collet C, et al. Reliability of tuberculin skin test measurement. Ann Intern Med 1997; 126: 210-4.
13. Quinn TC. Interactions of the human immunodeficiency virus and tuberculosis and the implications for BCG vaccination. Rev Infect Dis 1989; 11 (suppl 2): S379-S84.
14. World Health Organization. Expanded programme on immunization. Joint WHO/UNICEF statement on immunization and AIDS. WHO Weekly Epidemiol Rec 1987; 62: 53-4.